News

CHDS faculty Shafika Abrahams-Gessel and Thomas Gaziano and colleagues recently published a formative evaluation of the IMPACT-BP hypertension control trial in South Africa. In rural KwaZulu-Natal (KZN)

CHDS affiliate Yuli (Lily) Hsieh recently published a cost-effectiveness analysis of tuberculosis (TB) screening among US migrants. Between 2017 and 2021, 71% of TB cases were in non-U.S.-born individuals and the

CHDS faculty Jagpreet Chhatwal and co-author Rachael Fleurence published Realizing the Economic Potential of Meditation and Mindfulness Practices in Mental Health Care, a commentary

CHDS faculty Ankur Pandya presented Quantifying the Value of Representation in Clinical Trials at an Office of Educational Programs ‘Hot Topics’ seminar. Historically, clinical trials have

CHDS Adjunct Professor Uwe Siebert is teaching RDS 286: Decision Analysis in Clinical Research this summer, as he has for the past eleven years. Part of the Summer Program in Clinical Effectiveness

In conventional benefit-cost analysis, values are based on individuals’ willingness to exchange their own income for the outcomes they experience. Susan Chilton presented an alternative

Members of the CHDS community contributed to the 47th Annual Meeting of the Society of Medical Decision Making (SMDM), held in Ann Arbor, Michigan in June, 2025.

An important challenge for the use of screening and diagnostic tests is determining the threshold for defining whether the result is positive or negative, when the results are measured on a continuous

CHDS affiliate Allison Portnoy, Boston University assistant professor of global health, has been named a 2025 Junior Faculty Fellow at the Boston University Rafik B. Hariri Institute for Computing

CHDS faculty Jennifer Yeh and Zachary Ward and colleagues published a study in JAMA Oncology revealing that adult survivors of childhood cancer experience earlier onset and a higher lifetime risk of select chronic